Zobrazeno 1 - 10
of 101
pro vyhledávání: '"prekallikrein activator"'
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 22, Iss 1, Pp 49-59 (2022)
Assessment of prekallikrein content is essential for safety control of human immunoglobulin and albumin products. The inherent variability of human prekallikrein reagents and chromogenic substrates indicates the need for standardisation of the chromo
Externí odkaz:
https://doaj.org/article/37fe758fc7e4446e887bcdb59c0eb4c7
Publikováno v:
Standartnye Obrazcy, Vol 14, Iss 3-4, Pp 33-41 (2019)
Human immunoglobulin and human albumin products can negatively affect patients’ health. The residual content of haemagglutinins, anti-D antibodies, prekallikrein activator, as well as the level of anticomplementary activity, are controlled during b
Externí odkaz:
https://doaj.org/article/96e4db8a6b3e4fdb82bfa0e7d83fab2d
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 17, Iss 1, Pp 59-64 (2018)
Prekallikrein activator (PKA) is regarded as one of the most important factors determining the safety of blood products such as albumin and intravenous immunoglobulin. PKA impurity at a high concentration may cause undesired side effects when adminis
Externí odkaz:
https://doaj.org/article/e251624b66fb4d6a8954f2e35b8706a0
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Vox Sanguinis
Background Prekallikrein activator (PKA) is a contaminating enzyme found in therapeutic albumin and immunoglobulin products. The level is commonly measured using methods such as that defined by the European Pharmacopoeia (Ph Eur) with traceability to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67695760fb2e5141a800747c32b8105b
https://doi.org/10.1111/vox.12980
https://doi.org/10.1111/vox.12980
Publikováno v:
In Biologicals January 2012 40(1):79-83
Publikováno v:
Pharmaceutical Chemistry Journal. 53:267-271
Method development for determining prekallikrein activator in medicinal preparations of human immunoglobulins and albumin found that the adequacy of chromogenic determination of prekallikrein activator depends on the activity of the used prekallikrei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ade1e861ef69f25cad483900f727b06
https://doi.org/10.1007/s11094-019-01990-5
https://doi.org/10.1007/s11094-019-01990-5
Publikováno v:
Химико-фармацевтический журнал. 53:53-57
A method for determining the content of prekallikrein activator in preparations based on human immunoglobulins and albumin has been developed. It is found that the adequacy of determining the content of prekallikrein activator by the chromogenic meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56a264bc5021597dbd06015083e2b8b5
https://doi.org/10.30906/0023-1134-2019-53-3-53-57
https://doi.org/10.30906/0023-1134-2019-53-3-53-57
Publikováno v:
Pharmaceutical Chemistry Journal. 52:473-477
Modern technological approaches to ensuring the specific safety of human immunoglobulin and albumin preparations are analyzed. Introduction into human immunoglobulin preparation technology of donor screening for group- and rhesus-affiliations and chr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a506be808fc33e0eb3f3756f464da63
https://doi.org/10.1007/s11094-018-1842-1
https://doi.org/10.1007/s11094-018-1842-1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.